A Review of Venous Thromboembolism Risk Assessment and Prophylaxis in Plastic Surgery

• Published in: Plastic and reconstructive surgery (1963) Vol. 149; no. 1; pp. 121e - 129e
• Main Authors: Agrawal, Nikhil A., Hillier, Kirsty, Kumar, Riten, Izaddoost, Shayan A., Rohrich, Rod J.
• Format: Journal Article
• Language: English
• Published: United States Lippincott Williams & Wilkins 01-01-2022
• Subjects: Anticoagulants - administration & dosage; Humans; Postoperative Complications - epidemiology; Postoperative Complications - etiology; Postoperative Complications - prevention & control; Reconstructive Surgical Procedures - adverse effects; Risk Assessment - methods; Risk Assessment - statistics & numerical data; Risk Factors; Venous Thromboembolism - epidemiology; Venous Thromboembolism - etiology; Venous Thromboembolism - prevention & control
• ISSN: 0032-1052; 1529-4242
• DOI: 10.1097/PRS.0000000000008663

Venous thromboembolism is a significant cause of postoperative death and morbidity. While prophylactic and treatment regimens exist, they usually come with some risk of clinically relevant bleeding and, thus, must be considered carefully for each individual patient.
This special topic article represents a review of current evidence regarding venous thromboembolism risk, biology, and prevention in plastic surgery patients. The specific types and duration of available prophylaxis are also reviewed. The balance of venous thromboembolism risk must be weighed against the risk of hemorrhage.
Though alternatives exist, the most validated risk assessment tool is the 2005 modification of the Caprini Risk Assessment Model. Controversies remain regarding recommendations for outpatient and low risk cosmetic patients. The authors additionally make recommendations for high-risk patients regarding the use of tranexamic acid, estrogen therapy, anesthesia, and prophylaxis regimens.
Our profession has made great strides in understanding the science behind venous thromboembolism, risk stratification for patients, and prophylactic regimens; yet, continued studies and definitive data are needed.